Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

FDA Advertising and Promotion Enforcement Activities: Update

Alert September 12, 2019

This e-alert is part of a series of e-alerts summarizing publicly available FDA enforcement letters (i.e., warning letters and untitled letters) relating to the advertising and promotion of prescription drugs, medical devices, and biologics. In July and August, the Office of Prescription Drug Promotion (OPDP) posted enforcement letters on FDA’s website.

View More

Share links:

Share links:

Related Professionals

Related Practices

Related Offices

Related Regions

Related News & Insights